| 000 | 01607 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518081017.0 | ||
| 264 | 0 | _c20210222 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.02255-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiagi, M | |
| 245 | 0 | 0 |
_aActivity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c03 2020 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAzabicyclo Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 |
_aCarbapenem-Resistant Enterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aCeftazidime _xpharmacology |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xpharmacology |
| 650 | 0 | 4 |
_aMeropenem _xpharmacology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aSerratia Infections _xmicrobiology |
| 650 | 0 | 4 |
_aSerratia marcescens _xdrug effects |
| 650 | 0 | 4 |
_abeta-Lactamase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_abeta-Lactamases _xgenetics |
| 700 | 1 | _aShajee, A | |
| 700 | 1 | _aVialichka, A | |
| 700 | 1 | _aJurkovic, M | |
| 700 | 1 | _aTan, X | |
| 700 | 1 | _aWenzler, E | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 64 _gno. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.02255-19 _zAvailable from publisher's website |
| 999 |
_c30513366 _d30513366 |
||